2Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions [ J ] . Nat Med ,2001,7(5) :575-583.
3Pipp F, Hell M, Issbrucker K, et al. VEGFR- 1-Selective VEGF Homologue PIGF Is Arteriogenic:Evidence for a Monocyte-Mediated Mechanism[J]. Circ Res,2003,92(4) :378-385.
4Luttun A, Tjwa M, Moons L, et al. Revascularization of ischemic tissues by PIGF treatment, and inhibition of tumor anglogenesis, arthritis and atheroselerosis by anti-Fltl [J]. Nat Med,2002,8(8) : 831-840.
5Herold-Mende C, Steiner HH, Andl T, et al. Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells[J]. Lab Invest, 1999,79(12) : 1573-1582.
6Hiratsuka S,Maru Y,Okada A, et al .Involvement of Flt-1 tyrosine kinaae(vascular endothelial growth factor receptor- 1 ) in pathological angiogenesls[J]. Cancer Res,2001,61 (3) : 1207-1213.
7Autiero M,Waltenberger J,Communi D, et al. Role of PIGF in the intra-and intermolecular cross talk between the VEGF receptors Fltl and Flk1[J] .Nat Med,2003,9(7) :936-943.
8Cai J, Ahmad S, Jiang WG, et al. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells[J]. Diabetes, 2003,52 ( 12 ) : 2959-2968.
9Adini A, Kornaga T, Firoozhakht F, et al. Placental growth factor is a survival factor for tumor endothelial cells and macrophages[J]. Cancer Res, 2002,62(10) :2749-2752.
10Taylor AP, Osorio L, Craig R, et al. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy[J] .Clin Cancer Res,2002,8(4) : 1213-1222.
